statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31...

TherapeuticsMD Announces First Quarter 2024 Financial Results

TherapeuticsMD (TXMD) has provided an announcement. TherapeuticsMD, Inc., a healthcare company, announced its annual financial results for 2023 on...

TherapeuticsMD Announces 2023 Annual Financial Results

TherapeuticsMD, Inc. (TherapeuticsMD or the Company) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31...

TherapeuticsMD Announces Full Year 2023 Financial Results

Analysts at StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD  Get Free Report) in a research report issued on Friday. The firm set a hold rating on the...

TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com

Investment analysts at StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD  Get Free Report) in a note issued to investors on Saturday. The brokerage set a...

TherapeuticsMD (NASDAQ:TXMD) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD  Free Report) in a report released on Sunday. The firm issued a hold rating on the stock. TherapeuticsMD Stock...

TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com

StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD  Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the stock. TherapeuticsMD...

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD  Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a hold rating on the stock...

TherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.com

TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

Watchers	21,124
52-Wk Low	$1.84
52-Wk High	$4.52

Volume	10,449.00
52-Wk High	$4.52
52-Wk Low	$1.84

Period	Estimated	Reported	Surprise	Result
Q1'24	--	-$0.07	--	N/A
Q4'23	--	-$0.13	--	N/A
Q3'23	-$0.15	-$0.13	13.33%	BEAT
Q2'23	-$0.07	-$0.24	-242.86%	MISSED
Q1'23	$0.06	-$0.24	-500.00%	MISSED

TXMD TherapeuticsMD Inc

About

Feed

News

Sentiment

Earnings

Fundamentals